KaiBiLi RSV Antigen
Gabatarwa
RSV wakili ne mai saurin yaduwa, mai saurin yaduwa, kamuwa da cuta mai saurin kamuwa da cutar numfashi a cikin yara da tsofaffi.Kwayar cutar syncytial ta numfashi cuta ce ta RNA mai madauri guda ɗaya. Kusan rabin dukan yara sun kamu da cutar ta RSV a cikin shekarar farko ta rayuwarsu.Har ila yau, shine babban dalilin kamuwa da cuta na rashin lafiya a cikin yara da aka rigaya a asibiti don wasu dalilai. A duk duniya, an kiyasta cewa RSV ne ke da alhakin fiye da miliyan 30 na LRI a cikin yara 'yan ƙasa da shekaru 5 kowace shekara.
Hanyoyin bincike don gano ƙwayoyin cuta na numfashi sun haɗa da al'adar kwayar cutar kwayar cutar kwayar cuta, antibody fluorescent kai tsaye (DFA), saurin immunoassays, da ƙididdigar haɓakawa na nucleic acid irin su polymerase chain reaction (PCR). An nuna kowannensu yana da kayan aikin asibiti don gano ƙwayoyin cuta na numfashi ciki har da RSV.
Rap immunoassays samuwa ga takamaiman ƙwayoyin cuta irin su mura A/B da RSV suna ba da damar gano cutar cikin sauri ta yadda marasa lafiya za a iya ware su yadda ya kamata kuma a bi da su don hana yaduwar cututtuka na asibiti zuwa ga ’yan uwan marasa lafiya tare da raunin zuciya, numfashi ko ayyukan rigakafi.
Ganewa
Gwajin bincike don gano ƙimar ingancin ƙwayar cuta ta Syncytial (RSV) nucleoprotein antigens a cikin nasopharyngeal (NP) swab da samfuran aspirate na hanci,
Misali
Nasopharyngeal swab da Nasal aspirate ruwaye
Iyakar Ganewa (LoD)
Subtype | Iri | TCID50/ml |
A | RSV (dogon) | 32.5 |
B | RSV (nau'in daji) | 4×102 |
TCID50/mL = 50% Al'adar Nama mai Yaduwa
Daidaito
Hankali: 91.5%, Musamman: 96.8%
Lokaci zuwa sakamako
Karanta sakamako a cikin mintuna 15 kuma bai wuce mintuna 30 ba.
Yanayin ajiyar kayan aiki
2 ~ 30 ° C.
Abubuwan da ke ciki
Bayani | Qty |
RSV gwajin na'urorin | 20 |
Haifuwa swabs | 20 |
Buffer buffer cirewa | 20 |
Nozzles | 20 |
Bututun filastik | 20 |
Tube Tsaya | 1 |
Saka Kunshin | 1 |
Bayanin oda
Samfura | Cat. No. | Abubuwan da ke ciki |
KaiBiLiTMFarashin RSV | Saukewa: P211004 | 20 gwaje-gwaje |